Publication: Investigation on biological activities of anthranilic acid sulfonamide analogs
| dc.contributor.author | Doungsoongnuen S. | |
| dc.contributor.author | Worachartcheewan A. | |
| dc.contributor.author | Pingaew R. | |
| dc.contributor.author | Suksrichavalit T. | |
| dc.contributor.author | Prachayasittikul S. | |
| dc.contributor.author | Ruchirawat S. | |
| dc.contributor.author | Prachayasittikul V. | |
| dc.date.accessioned | 2021-04-05T03:34:47Z | |
| dc.date.available | 2021-04-05T03:34:47Z | |
| dc.date.issued | 2011 | |
| dc.date.issuedBE | 2554 | |
| dc.description.abstract | In the previous studies, the cytotoxicities of anthranilate sulfonamides were investigated. Herein, the bioactivities of 4-substituted (X = NO2, OCH3, CH3, Cl) benzenesulfonamides of anthranilic acid (5-8) are reported. The results revealed that all sulfonamides selectively exerted antifungal activity (25-50% inhibition) against C. albicans at 4 μg/mL. Furthermore, compounds 6 and 8 show antioxidative (SOD) activity. These sulfonamides, except for 6, selectively display cytotoxic effects toward MOLT-3 cells. It is interesting to note that sulfonamides with electron withdrawing substituent (5, X = NO2) exhibited the highest cytotoxicity. This study provided preliminary structure-activity relationship of the anthranilic sulfonamides that is useful for further in-depth investigation. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | EXCLI Journal. Vol 10, (2011), p.155-161 | |
| dc.identifier.issn | 16112156 | |
| dc.identifier.other | 2-s2.0-84855815989 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/7198 | |
| dc.rights.holder | มหาวิทยาลัยศรีนครินทรวิโรฒ | |
| dc.subject.other | 2 (4' chlorophenylsulfonamido)benzoic acid | |
| dc.subject.other | 2 (4' methoxyphenylsulfonamido)benzoic acid | |
| dc.subject.other | 2 (4' methylphenylsulfonamido)benzoic acid | |
| dc.subject.other | 2 (4' nitrophenylsulfonamido)benzoic acid | |
| dc.subject.other | Ampicillin | |
| dc.subject.other | Antifungal agent | |
| dc.subject.other | Antiinfective agent | |
| dc.subject.other | Antioxidant | |
| dc.subject.other | Benzenesulfonamide derivative | |
| dc.subject.other | Cytotoxic agent | |
| dc.subject.other | Doxorubicin | |
| dc.subject.other | Etoposide | |
| dc.subject.other | Unclassified drug | |
| dc.subject.other | Antifungal activity | |
| dc.subject.other | Antioxidant activity | |
| dc.subject.other | Article | |
| dc.subject.other | Candida albicans | |
| dc.subject.other | Concentration response | |
| dc.subject.other | Controlled study | |
| dc.subject.other | Cytotoxicity | |
| dc.subject.other | Drug mechanism | |
| dc.subject.other | Drug structure | |
| dc.subject.other | Human | |
| dc.subject.other | Human cell | |
| dc.subject.other | Minimum inhibitory concentration | |
| dc.subject.other | Nonhuman | |
| dc.subject.other | Structure activity relation | |
| dc.title | Investigation on biological activities of anthranilic acid sulfonamide analogs | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855815989&partnerID=40&md5=9815e2911bcb9dea89cdcaaca0c01b43 |
